Timber Pharmaceuticals, Inc.
TMBR
TMBR was delisted on the 28th of November, 2023.
3 hedge funds and large institutions have $443K invested in Timber Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
50% more funds holding
Funds holding: 2 → 3 (+1)
72% less capital invested
Capital invested by funds: $1.58M → $443K (-$1.14M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$55.5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$27.7K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RI
1
RTW Investments
New York
| $382K | – | – | – |
|
|
2
Millennium Management
New York
| $36K | +$55.5K | +2 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $20K | +$27.7K | +1 | New |
|
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $5K | – | – | – |
|
TMBR Hedge Fund Activity: Q3 2015 in Review
3 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Timber Pharmaceuticals, Inc. (TMBR) for Q3 2015, worth a combined $443K — down 72% from $1.58M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new TMBR positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $55.5K.
- 3 institutional investors held Timber Pharmaceuticals, Inc. (TMBR) as of Q3 2015, up from 2 in Q2 2015.
- Funds reported $443K of Timber Pharmaceuticals, Inc. stock for Q3 2015, down 72% quarter-over-quarter.
- 2 funds opened new Timber Pharmaceuticals, Inc. positions in Q3 2015 and 0 closed out, a net change of +2 holders.
- The largest Timber Pharmaceuticals, Inc. buyer in Q3 2015 was Millennium Management, an estimated $55.5K added.
Based on aggregated 13F filings for Q3 2015.